Related Experiment Videos

Methods and endpoint issues in clinical development of lipid-acting agents with pleiotropic effects

¹Hyperlipidemia and Atherosclerosis Research Group, Clinical Research Institute of Montreal, QC, Canada.

The American Journal of Cardiology

|May 30, 1998

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

A PCSK9 variant and familial combined hyperlipidaemia.

Journal of medical genetics·2008

Biochemical and bioimaging markers for risk assessment and diagnosis in major cardiovascular diseases: a road to integration of complementary diagnostic tools.

Journal of internal medicine·2007

Cardioprotective and other emerging effects of statins.

International journal of clinical practice. Supplement·2005

Advances in lipid-lowering therapy in atherosclerosis.

Advances in experimental medicine and biology·2002

Moderate intake of n-3 fatty acids is associated with stable erythrocyte resistance to oxidative stress in hypertriglyceridemic subjects.

The American journal of clinical nutrition·2001

Interaction of lecithin:cholesterol acyltransferase (LCAT).alpha 2-macroglobulin complex with low density lipoprotein receptor-related protein (LRP). Evidence for an alpha 2-macroglobulin/LRP receptor-mediated system participating in LCAT clearance.

The Journal of biological chemistry·2001

See all related articles